Cargando…
Sacubitril/Valsartan for heart failure: A protocol for systematic review and meta-analysis
BACKGROUND: Sacubitril–valsartan has been shown to have superior effects over angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with heart failure (HF). However, the effects of sacubitril–valsartan have never been systematically evaluated. Therefore, we performed...
Autores principales: | Dai, Wenqin, Luo, Jinlan, Huang, Xianli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276214/ https://www.ncbi.nlm.nih.gov/pubmed/35687770 http://dx.doi.org/10.1097/MD.0000000000029149 |
Ejemplares similares
-
Efficacy and safety of sacubitril-valsartan in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials: A PRISMA-compliant article
por: Lin, Jiezhong, et al.
Publicado: (2021) -
Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
por: Ye, Fanhao, et al.
Publicado: (2022) -
Support with Impella versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: A protocol for systematic review and meta-analysis
por: Rao, Lingzhang, et al.
Publicado: (2021) -
A study of the sequential treatment of acute heart failure with sacubitril/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial
por: Pang, Zhihua, et al.
Publicado: (2021) -
Use of sacubitril/valsartan in Marfan syndrome–related cardiomyopathy: The first case report
por: Spoto, Silvia, et al.
Publicado: (2019)